Potassium Chloride NDC 72888-097

NDC codes

FDA NDC Directory

Product NDC (as listed)72888-097Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72888-0097Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72888-097-00	72888009700	1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-097-00)Marketed from Jun 16, 2023
72888-097-01	72888009701	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-097-01)Marketed from Jun 16, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Potassium Chloride
Generic name (nonproprietary): potassium chloride
Active ingredients: Potassium chloride — 750 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Advagen Pharma Ltd.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 216321
Marketing start: Jun 16, 2023
Listing expires: Dec 31, 2027
Other FDA classes: Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)Potassium Compounds (Chemical structure)
Identifiers: Product ID 72888-097_47c7b555-0f26-f6ff-e063-6294a90a05ceSPL ID 47c7b555-0f26-f6ff-e063-6294a90a05ceSPL set ID f4497c26-da16-45b0-975d-81f2c2132704RxCUI 403888, 1801294, 1801298UNII 660YQ98I10UPC 0372888098012, 0372888099002, 0372888097008, 0372888097015, 0372888098005, 0372888099019
Pharmacologic class: Osmotic Laxative; Potassium Salt

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472888009700 followed by a unit qualifier and the quantity

Package 72888-0097-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 7, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE BECAUSE OF REPORTS OF INTESTINAL AND GASTRIC ULCERATION AND BLEEDING WITH CONTROLLED-RELEASE POTASSIUM CHLORIDE PREPARATIONS, THESE DRUGS SHOULD BE RESERVED FOR THOSE PATIENTS WHO CANNOT TOLERATE OR REFUSE TO TAKE LIQUID OR EFFERVESCENT POTASSIUM PREPARATIONS OR FOR PATIENTS IN WHOM THERE IS A PROBLEM OF COMPLIANCE WITH THESE PREPARATIONS. For the treatment of patients with hypokalemia with or without metabolic alkalosis, in digitalis intoxication and in patients with hypokalemic familial periodic paralysis. If hypokalemia is the result of diuretic therapy, consideration should be given to the use of a lower dose of diuretic, which may be sufficient without leading to h…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 216321

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 216321
Product	Strength	Form · route	Labeler	Product NDC
Potassium Chloride	Potassium chloride 1125 mg/1	Tablet, Extended releaseOral	Advagen Pharma Ltd.	72888-098
Potassium Chloride	Potassium chloride 1500 mg/1	Tablet, Extended releaseOral	Advagen Pharma Ltd.	72888-099